Investigating how immune responses in the body and brain affect cognitive decline in aging and Alzheimer's disease
Official title: The role of peripheral versus brain myeloid immunity in the cognitive decline of aging and Alzheimer's disease
Funded at Stanford University · NIH-10524957 · Data updated 2026-11-12
This study is looking at how immune cells in the brain and body affect memory and thinking problems that come with aging and Alzheimer's disease, and it’s for older adults who want to understand more about what might help keep their minds sharp.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | August 15, 2022 |
| Project end | July 31, 2025 |
| Funding year | 2022 |
| Award (this year) | $1,749,426 |
| NIH project number | 1RF1AG079131-01 |
| Project ID | NIH-10524957 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults experiencing cognitive decline or those at risk for Alzheimer's disease.
✕Less likely to help
Patients with cognitive decline due to non-aging related factors may not benefit from this research.
What this research studies
This research explores the impact of immune responses from both the brain and the peripheral body on cognitive decline associated with aging and Alzheimer's disease. It aims to understand how changes in immune cells outside the brain, known as peripheral myeloid cells, contribute to cognitive issues, alongside the role of brain-specific immune cells called microglia. By using innovative techniques, the study will compare the effects of these two immune systems on cognitive health in aging and Alzheimer's models. This could lead to new insights into how to prevent or treat cognitive decline in older adults.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating cognitive decline in aging and Alzheimer's disease.
How similar studies have gone: Previous research has shown promising results in understanding the role of immune responses in cognitive decline, but this specific approach is relatively novel.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Andreasson, Katrin I. — Stanford University
- Study coordinator: Andreasson, Katrin I.
Related research
Other NIH-funded projects on the same topics.
-
How immune cells in the body versus the brain affect memory loss in aging and Alzheimer's
Researchers are comparing whether immune cells in the blood or immune cells in the brain drive memory loss in older adults and people with Alzheimer's.
-
Addressing Alzheimer’s and related dementias and metal exposure in older adults in Bangladesh
This project looks at how lifetime exposure to metals might influence memory loss and dementia risk in people aged 65 and older in Bangladesh, with the goal of finding early blood biomarkers.
-
Understanding brain fluid spaces in aging and Alzheimer's disease
This project explores how tiny fluid-filled spaces in the brain change as we age and in people with early Alzheimer's disease.
-
Investigating changes in brain fluid spaces related to aging and Alzheimer's disease
This study is looking at special spaces in the brain that help remove waste, to see how they change as we age and in the early stages of Alzheimer's disease, so we can better understand brain health and find early signs of cognitive decline.
-
Investigating how breathing problems after a stroke affect thinking skills in older adults with Alzheimer's disease.
This study is looking at how breathing problems after a stroke might affect thinking and memory in older adults, especially those with Alzheimer's or certain brain conditions, to find ways to help improve both breathing and brain health.
-
How COVID-19 infection and genes may influence memory and dementia risk
This study looks at how getting COVID-19 and a person’s genes together affect the chance of developing memory problems and Alzheimer’s disease later in life.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.